An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Reata Pharmaceuticals, Inc.. Investors who are current long term investors in Reata Pharmaceuticals, Inc. (NASDAQ: RETA) shares, have certain options and should contact theInvestigation for Long-Term Investors in shares of Reata Pharmaceuticals, Inc. (NASDAQ: RETA) announced | openPR.com - New Public Relations: Business, Economy, Finances, Banking & Insurance
An investigation was announced concerning potential breaches of fiduciary duties by certain directors and officers of Reata Pharmaceuticals, Inc.. Investors who are current long term investors in Reata Pharmaceuticals, Inc. (NASDAQ: RETA) shares, have certain options and should contact the